These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 2225564)

  • 1. Hypophosphatemia in infants on continuous ambulatory peritoneal dialysis.
    Roodhooft AM; Van Hoeck KJ; Van Acker KJ
    Clin Nephrol; 1990 Sep; 34(3):131-5. PubMed ID: 2225564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low prevalence of hyperphosphatemia independent of residual renal function in peritoneal dialysis patients.
    Dong J; Wang H; Wang M
    J Ren Nutr; 2007 Nov; 17(6):389-96. PubMed ID: 17971311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Influencing factors in the control of phosphorus in peritoneal dialysis. Therapeutic options].
    Gallar P; Ortega O; Gutiérrez M; Muñoz M; Hilara L; Oliet A; Rodríguez I; Giménez E; Vigil A
    Nefrologia; 2000; 20(4):355-61. PubMed ID: 11039261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypophosphatemic effect of 1% amino acid dialysis solution.
    Arfeen S; Kirkwood A; Goodship TH; Ward MK
    Adv Perit Dial; 1989; 5():167-70. PubMed ID: 2577404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aluminum concentrations in serum, dialysate, urine and bone among patients undergoing continuous ambulatory peritoneal dialysis (CAPD).
    Joffe P; Olsen F; Heaf JG; Gammelgaard B; Pödenphant J
    Clin Nephrol; 1989 Sep; 32(3):133-8. PubMed ID: 2791364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcium alginate, an aluminum-free phosphate binder, in patients on CAPD.
    Passlick J; Wilhelm M; Busch T; Grabensee B; Ohnesorge FK
    Clin Nephrol; 1989 Aug; 32(2):96-100. PubMed ID: 2766587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous ambulatory peritoneal dialysis: three years' experience.
    Ramos JM; Gokal R; Siamopolous K; Ward MK; Wilkinson R; Kerr DN
    Q J Med; 1983; 52(206):165-86. PubMed ID: 6611839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Dynamic changes in calcium and phosphate plasma concentrations in the patients on peritoneal dialysis].
    Jovanović N; Lausević M; Stojimirović B
    Vojnosanit Pregl; 2006 Jan; 63(1):27-30. PubMed ID: 16471245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcium carbonate as a phosphate binder in children on continuous ambulatory peritoneal dialysis and hemodialysis.
    Sieniawska M; Roszkowska-Blaim M; Weglarska J; Jabłczyńska A; Welc-Dobies J
    Mater Med Pol; 1991; 23(3):203-8. PubMed ID: 1842716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence of central hypothyroidism in children on continuous ambulatory peritoneal dialysis.
    Düsünsel R; Poyrazoglu HM; Gündüz Z; Kurtoglu S; Kiris A; Günes T
    Adv Perit Dial; 1999; 15():262-8. PubMed ID: 10682115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth in children treated with continuous ambulatory peritoneal dialysis.
    Kohaut EC
    Int J Pediatr Nephrol; 1983 Jun; 4(2):93-8. PubMed ID: 6618774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal osteodystrophy in children undergoing continuous ambulatory peritoneal dialysis.
    Hewitt IK; Stefanidis C; Reilly BJ; Kooh SW; Balfe JW
    J Pediatr; 1983 Nov; 103(5):729-34. PubMed ID: 6631599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nutritional behaviour of patients on continuous ambulatory peritoneal dialysis.
    von Baeyer H; Gahl GM; Riedinger H; Borowzak B; Kessel M
    Proc Eur Dial Transplant Assoc; 1981; 18():193-8. PubMed ID: 7329967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous ambulatory peritoneal dialysis with a high flux membrane. A preliminary report.
    Nolph KD; Moore HL; Prowant B; Twardowski ZJ; Khanna R; Gamboa S; Keshaviah P
    ASAIO J; 1993; 39(3):M566-8. PubMed ID: 8268600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Residual renal function in children treated with continuous ambulatory peritoneal dialysis or automated peritoneal dialysis--a preliminary study.
    Roszkowska-Blaim M; Skrzypczyk P; Drozdz D; Pietrzyk JA
    Adv Perit Dial; 2009; 25():103-9. PubMed ID: 19886329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Higher KT/V urea associated with greater protein catabolic rate and dietary protein intake in children treated with CCPD compared to CAPD. Mid-European Pediatric CPD Study Group (MPCS).
    Schaefer F; Wolf S; Klaus G; Langenbeck D; Mehls O
    Adv Perit Dial; 1994; 10():310-4. PubMed ID: 7999855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atrial natriuretic peptide (ANP) is removed by peritoneal dialysis in humans.
    Fincher ME; Campbell HT; Sklar AH; Caruana RJ; Lightfoot BO; Cheek PL; Smith KL; Hess CP
    Adv Perit Dial; 1989; 5():16-9. PubMed ID: 2577402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chronic ambulatory peritoneal dialysis].
    Glasson P; Leski M; Favre H
    Schweiz Med Wochenschr; 1981 Aug; 111(34):1232-8. PubMed ID: 7025196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recommendations for dietary protein intake in CAPD patients.
    Piraino B
    Adv Perit Dial; 1996; 12():275-9. PubMed ID: 8865918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.